Robin John Shattock is professor of mucosal infection and immunity at the Faculty of Medicine, Imperial College London. During the COVID-19 pandemic, Shattock led the British initiative to develop a vaccine for the disease at Imperial. He estimated in February 2020 that the vaccine for the disease would be available by early 2021. Shattock is an international leader in the field of mucosal immunology and HIV prevention. He has been a pioneer in investigating the use of drugs and passive antibodies to prevent HIV transmission, first showing that they work in vitro and then translating to clinical trials.